Edwards Lifesciences Corp·4

May 4, 7:29 PM ET

Chopra Daveen 4

4 · Edwards Lifesciences Corp · Filed May 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Edwards Lifesciences (EW) CVP Daveen Chopra Surrenders 282 Shares for Taxes

What Happened
Daveen Chopra, CVP, TMTT & Surgical at Edwards Lifesciences, had 282 shares withheld/surrendered on May 3, 2026 to satisfy a tax liability (Form 4 transaction code F). The shares were valued at $83.98 each, totaling $23,682. This was a tax-withholding disposal of shares—routine administrative action—not an open-market sale.

Key Details

  • Transaction date and price: 2026-05-03; 282 shares at $83.98/share (total $23,682).
  • Transaction code: F — payment of exercise price or tax liability via share withholding.
  • Shares owned after transaction: not specified in the excerpt of the filing.
  • Filing timeliness: Report period 2026-05-03; Form 4 filed 2026-05-04 (appears timely).
  • Filing note: Form states it “reflects changes in beneficial ownership only” and may not list other holdings.

Context
A code F withholding is typically used to cover taxes from vested awards or option exercises and is an administrative step rather than a directional trade by the insider. Such disposals are common and don’t necessarily indicate the insider’s view on the company. Retail investors tracking meaningful insider signals should prioritize open-market purchases or large sales over routine tax-withholding transactions.

Insider Transaction Report

Form 4
Period: 2026-05-03
Chopra Daveen
CVP, TMTT & Surgical
Transactions
  • Tax Payment

    Common Stock

    2026-05-03$83.98/sh282$23,68231,919 total
Signature
Linda J. Park, Attorney-in-Fact|2026-05-04

Documents

1 file
  • 4
    doc4.xmlPrimary